October 25th 2024
On October 25, 2024, Kind Pharmaceutical announced receipt of FDA Orphan Drug Designation for AND017 in the treatment of sickle cell disease.
Clinician Quiz: Role of Adjunctive Tests in Diagnosing Iron Deficiency Anemia
January 25th 2024Test your knowledge with this clinician quiz! In this quiz, we test your knowledge of adjunctive tests in the diagnosis of iron deficiency anemia based on recommendations from the 2020 American Gastroenterological Association's clinical practice guidelines on gastrointestinal evaluation of iron deficiency anemia.
FDA Approves Iptacopan (Fabhalta) for Paroxysmal Nocturnal Hemoglobinuria
December 6th 2023The approval was based on data from the APPLY-PNH trial and APPOINT-PNH study, which showed iptacopan was superior for hemoglobin improvement in the absence of red blood cell transfusions and in transfusion avoidance rate compared to patients who stayed on anti-C5 treatments.
Deeper Anemia Linked to Higher Risk of Bleeding, Stroke in Patients Treated with Warfarin
Severity-dependent anemia and low hemoglobin levels were significant risk factors for stroke/transient ischemic attack and bleeding in patients with atrial fibrillation treated with warfarin.
Study Details AKI Prevalence, Risk Factors in Infant Liver Transplant Patients
November 9th 202360.2% of infant living-related liver transplant recipients developed AKI within 7 days of surgery and experienced more frequent serious complications, longer hospital stays, and a greater duration of postoperative mechanical ventilation compared to those who did not develop AKI.
Eltrombopag Demonstrates Safety, Efficacy in Patients with Severe Aplastic Anemia
Research demonstrates eltrombopag is a safe and effective treatment option for patients with refractory or relapsed severe aplastic anemia, with 70% of patients achieving hematologic response at week 26.
Study Explores High Prevalence of Anemia in Children Under 5 Years Old in Ghana
November 9th 2023Investigators studied factors that could be associated with anemia in children < 5 years old, such as gender, age in years, type of birth (single or multiple), birth order, preceding birth interval in months (<18 months, 18+ months, or 1st born), and fever or no fever in the past 2 weeks (with malaria and without). Other factors related to mother or caregiver characteristics and household characteristics.